These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Zinc chelatase in human lymphocytes: detection of the enzymatic defect in erythropoietic protoporphyria. Nunn AV, Norris P, Hawk JL, Cox TM. Anal Biochem; 1988 Oct; 174(1):146-50. PubMed ID: 3218729 [Abstract] [Full Text] [Related]
4. Accumulation of protoporphyrin IX from delta-aminolevulinic acid in bovine skin fibroblasts with hereditary erythropoietic protoporphyria. A gene-dosage effect. Sassa S, Schwartz S, Ruth G. J Exp Med; 1981 May 01; 153(5):1094-101. PubMed ID: 6788885 [Abstract] [Full Text] [Related]
7. Protoporphyrin accumulation by mitogen stimulated lymphocytes and protoporphyrinogen oxidase activity in patients with porphyria variegata and erythropoietic protoporphyria: evidence for deficiency of protoporphyrinogen oxidase and ferrochelatase in both diseases. Siepker LJ, Kramer S. Br J Haematol; 1985 May 01; 60(1):65-74. PubMed ID: 3924091 [Abstract] [Full Text] [Related]
8. X-linked dominant protoporphyria: The first reported Japanese case. Ninomiya Y, Kokunai Y, Tanizaki H, Akasaka E, Nakano H, Moriwaki S. J Dermatol; 2016 Apr 01; 43(4):414-8. PubMed ID: 26387792 [Abstract] [Full Text] [Related]
10. Different characteristics of ferrochelatase in cultured fibroblasts of erythropoietic protoporphyria patients and normal controls. Blom C, Klasen EC, Van Steveninck J. Biochim Biophys Acta; 1990 Jul 06; 1039(3):339-42. PubMed ID: 2378891 [Abstract] [Full Text] [Related]
11. The biosynthesis of haem in congenital (erythropoietic) porphyria. Moore MR, Thompson GG, Goldberg A, Ippen H, Seubert A, Seubert S. Int J Biochem; 1978 Jul 06; 9(12):933-8. PubMed ID: 744299 [No Abstract] [Full Text] [Related]
12. Protoporphyrinogen oxidase and ferrochelatase in porphyria variegata. Viljoen DJ, Cummins R, Alexopoulos J, Kramer S. Eur J Clin Invest; 1983 Aug 06; 13(4):283-7. PubMed ID: 6413214 [Abstract] [Full Text] [Related]
14. Enzyme abnormalities in the porphyrias. Brodie MJ, Moore MR, Goldberg A. Lancet; 1977 Oct 01; 2(8040):699-701. PubMed ID: 71507 [Abstract] [Full Text] [Related]
15. Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria. Balwani M, Doheny D, Bishop DF, Nazarenko I, Yasuda M, Dailey HA, Anderson KE, Bissell DM, Bloomer J, Bonkovsky HL, Phillips JD, Liu L, Desnick RJ, Porphyrias Consortium of the National Institutes of Health Rare Diseases Clinical Research Network. Mol Med; 2013 Apr 30; 19(1):26-35. PubMed ID: 23364466 [Abstract] [Full Text] [Related]
16. Ferrochelatase activities in patients with erythropoietic protoporphyria and their families. Goerz G, Bunselmeyer S, Bolsen K, Schürer NY. Br J Dermatol; 1996 May 30; 134(5):880-5. PubMed ID: 8736329 [Abstract] [Full Text] [Related]